Speaker illustration

Doctor Daniel Chirino

Hospital Franchin, Buenos Aires (Argentina)

He is a specialist doctor in Internal Medicine and Cardiology (University of Buenos Aires). He is a staff physician of cardiology of the Sanatorio Franchín and the Cesar Milstein Hospital (Buenos Aires, Argentina), in charge of the clinical research area in both services. Since 2016, he is Coordinator of the Heart Failure and Chagas disease program at the Sanatorio Franchín and the Heart Failure program at the Cesar Misltein Hospital. He is titular member of Argentine Society of Cardiology. During 2019, he was the Coordinator of Health Technology Assesement of the Superintendency of Health Services (dependening on the Ministry of Health of the Argentine Republic); and member of the National Commission of Health Technology Assesement (CONETEC). He currently works as a medical consultant in Helath Technology Assesement.

Comparison of CRUSADE and ORBIT bleeding risk scores in prediction of mayor bleeding in pacients with acute coronary syndrome

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Acute coronary syndromes - Risks

Thumbnail

Higth-sensitivity T troponin and NT pro B-type natriuretic peptide as predictors of early development of structural heart disease in patients with stage 0 of Chagas disease.

Event: ESC Congress 2021 - The Digital Experience

Topic: Chagas’ Disease

Session: Myocardial and pericardial disease e-posters

Thumbnail

Incremental value of hyponatremia to the ADHERE risk tree to predict in-hospital mortality in patients with acute heart failure.

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure e-posters

Thumbnail

Leuko-platelet index as an independent predictor of in-hospital events in patients with non-ST elevation acute coronary syndrome

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Coronary Syndromes ePosters

Thumbnail

Association between the elevation of biomarkers and incipient alterations in ventricular function in patients with Chagas disease without evidence of specific organ damage.

Event: ESC Congress 2020

Topic: Chagas’ Disease

Session: Myocardial Disease ePosters

Thumbnail

High sensitive cardiac troponin elevations in patients with Chagas disease without evidence of structural heart affection

Event: ESC Congress 2018

Topic: Chagas’ Disease

Session: Various cardiomyopahies

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb